Health Research, Inc.

Health Research, Inc., a tax-exempt nonprofit based in Menands, New York, delivers epidemiological research, vital statistics data collection and analysis, disease surveillance, and public health program implementation services to the federal government as a prime contractor (95% of recent awards) and grant recipient, competing full-and-open across civilian health and science agencies without set-aside designations.

HRI's customer concentration sits heavily with Department of Health and Human Services components. The top five funding agencies by combined potential value account for 72% of awards: CDC Office of Acquisition Services (19 awards, $69 million combined potential value), CDC Pittsburgh (46 awards, $66.8 million), the Social Security Administration (35 awards, $19.3 million), NIH's National Institute of Child Health and Human Development (5 awards, $14.9 million), and NIH's National Cancer Institute (9 awards, $9.1 million). By award count, CDC (combined Pittsburgh and OAS units) leads with 142 awards, followed by SSA with 35, Health Resources and Services Administration with 33, and the National Science Foundation with 29. This concentration reflects HRI's deep embeddedness in federal vital statistics, newborn screening, and infectious-disease surveillance ecosystems.

Representative prime contract work includes a $9.9 million cost-no-fee definitive contract from the National Institute of Allergy and Infectious Diseases to discover and characterize human B cell epitopes on bacterial surface antigens involved in Borrelia burgdorferi immunity (completion September 2029), a $5.04 million Social Security Administration purchase order for electronic death records program management in New York (running through December 2028), a $664,296 CDC delivery order for Vital Statistics Cooperative Program data collection and reporting in New York (one of multiple recurring annual orders under a $5.32 million CDC IDC through April 2027), and a $1.03 million NICHD delivery order for newborn screening pilot studies on metachromatic leukodystrophy. On the grant side, HRI holds cooperative agreements as prime recipient from the CDC for public health emergency preparedness (PHEP, ultimate completion June 2029), hospital preparedness programs (HPP, June 2029), epidemiology and laboratory capacity for emerging infectious diseases (ELC, July 2029), and public health crisis response (January 2027); from the Bureau of Labor Statistics for occupational safety and health statistics collection in New York (ongoing, CFDA 17.005); and from the Office of the Assistant Secretary for Preparedness and Response for medical reserve corps modernization (May 2026). HRI also holds grant sub-awards from Emory University on cancer surveillance work, from the Research Foundation for SUNY on health workforce planning technical assistance, and from the University of Arizona on cancer prevention networks.

Activity has grown from eight awards in 2022 to twenty-one in 2024, before declining to fourteen in 2025 and three awarded year-to-date in 2026; this recent contraction warrants watching. Awards reaching ultimate completion within the next twenty-four months carry combined potential value of $5.3 million (21 awards), representing moderate recompete exposure. HRI holds seats on five named IDIQs anchoring its base of task-order work: a CDC Basic Ordering Agreement (HHSD200201250832I, 9 task orders, $3.9 million potential value), two CDC Indefinite Delivery Contracts (HHSD200201792609I with 9 task orders and $4.1 million potential value; HHSD200200100075I with 7 task orders and $8.9 million potential value), and two Social Security Administration IDCs (SS000660042 with 8 task orders, $465 thousand; SS000860050 with 8 task orders, $1.9 million). The NIH NICHD newborn screening IDC (awarded September 2021, $9 million ceiling, through September 2027) has generated four task orders worth approximately $5.9 million collectively.

Across SCI-reportable prime service contracts, invoiced federal revenue totaled $6.1 million over FY2022–FY2024 ($3.1 million in FY2022, $399 thousand in FY2023, $2.6 million in FY2024), with a workforce footprint of 429 FTEs in FY2022 contracting sharply to 0.4 FTEs in FY2023 before recovering to 27 FTEs in FY2024 — indicating episodic or variable staffing on captured federal service contracts. Government-paid rates on SCI-reportable prime contracts ranged from a 10th percentile of $6.33 per hour through a median of $30.57 per hour to a 90th percentile of $626.91 per hour, reflecting a wide spectrum from administrative labor through senior research and scientific expertise. Across SCI-reportable prime contracts, subcontractors accounted for 4% of total contractor hours on average, with 18 named subcontractors, indicating HRI builds most delivery capacity internally rather than relying on deep subcontracting networks.

HRI's award portfolio spans data administration and management (42 awards under PSC support-administrative / information retrieval), public health program administration (35 awards under support-management / data collection), medical applied research and exploratory development (14 awards under R&D-medical / other), and general consulting services (18 awards under administrative management consulting). The nonprofit structure and tax-exempt status position HRI as a quasi-public research arm aligned with state and federal public health agencies; the source lists seven named entity registrations of Health Research, Inc. under different organizational subtypes, likely reflecting subsidiary legal entities or historical registrations rather than operationally distinct subsidiaries.